Loading organizations...
Loading organizations...
Clinical stage pharmaceutical company developing cancer and neurology thera
Cavion has raised $26.1M across 1 funding round.
Cavion has raised $26.1M in total across 1 funding round.
Cavion has raised $26.1M in total across 1 funding round.
Cavion's investors include Sergei Petukhov, Steve Hall, Henry Skinner.
Cavion has raised $26.1M across 1 funding round. Most recently, it raised $26.1M Series A in January 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 6, 2017 | $26.1M Series A | Sergei Petukhov, Steve Hall, Henry Skinner |